Table 1. Top 100 Drugs by Sales | ||
Rank | Drug (Brand Name) | Sales Through March 2014 |
1 | Abilify | $6,885,243,368 |
2 | Nexium | $6,271,376,299 |
3 | Humira | $5,936,288,498 |
4 | Crestor | $5,502,148,010 |
5 | Advair Diskus | $5,112,576,549 |
6 | Enbrel | $4,896,267,318 |
7 | Remicade | $4,235,535,358 |
8 | Cymbalta | $4,095,537,942 |
9 | Copaxone | $3,679,837,035 |
10 | Neulasta | $3,634,919,067 |
11 | Lantus Solostar | $3,375,632,862 |
12 | Rituxan | $3,320,475,967 |
13 | Spiriva Handihaler | $3,140,602,715 |
14 | Januvia | $2,975,320,499 |
15 | Atripla | $2,894,627,347 |
16 | Lantus | $2,796,784,267 |
17 | Avastin | $2,742,284,655 |
18 | Lyrica | $2,611,451,728 |
19 | Oxycontin | $2,528,601,587 |
20 | Epogen | $2,346,224,521 |
21 | Celebrex | $2,342,549,444 |
22 | Truvada | $2,307,970,304 |
23 | Diovan | $2,190,542,692 |
24 | Gleevec | $1,995,042,989 |
25 | Herceptin | $1,971,724,243 |
26 | Lucentis | $1,917,919,037 |
27 | Namenda | $1,871,956,353 |
28 | Vyvanse | $1,848,814,801 |
29 | Zetia | $1,826,260,072 |
30 | Levemir | $1,775,037,064 |
31 | Symbicort | $1,733,830,589 |
32 | Sovaldi | $1,724,867,241 |
33 | Novolog Flexpen | $1,482,659,229 |
34 | Novolog | $1,409,680,368 |
35 | Tecfidera | $1,394,704,148 |
36 | Suboxone | $1,388,805,102 |
37 | Humalog | $1,310,236,982 |
38 | Xarelto | $1,263,697,546 |
39 | Seroquel XR | $1,251,615,894 |
40 | Viagra | $1,235,125,299 |
41 | Alimta | $1,205,717,422 |
42 | Victoza 3-Pak | $1,186,784,355 |
43 | Avonex | $1,184,476,004 |
44 | Nasonex | $1,180,165,756 |
45 | Cialis | $1,170,843,904 |
46 | Gilenya | $1,097,409,827 |
47 | Stelara | $1,083,660,282 |
48 | Flovent HFA | $1,078,422,967 |
49 | Prezista | $1,046,464,870 |
50 | Procrit | $1,037,298,436 |
51 | Isentress | $1,037,220,122 |
52 | Janumet | $1,028,179,032 |
53 | Renvela | $1,023,751,529 |
54 | Humalog Kwikpen | $1,003,100,788 |
55 | Orencia | $990,449,529 |
56 | Dexilant | $967,408,551 |
57 | Vesicare | $967,408,277 |
58 | Neupogen | $944,389,150 |
59 | Reyataz | $935,417,307 |
60 | Lunesta | $927,689,337 |
61 | Synthroid | $899,215,664 |
62 | Pradaxa | $862,604,444 |
63 | Zytiga | $861,683,197 |
64 | Benicar | $860,761,655 |
65 | Xolair | $859,052,353 |
66 | Avonex Pen | $849,256,894 |
67 | Vytorin | $846,602,646 |
68 | Invega Sustenna | $831,061,694 |
69 | Sensipar | $824,871,721 |
70 | Xgeva | $822,603,435 |
71 | Prevnar 13 | $821,372,081 |
72 | Evista | $815,315,970 |
73 | Aranesp | $814,017,366 |
74 | Betaseron | $792,093,855 |
75 | Stribild | $785,645,319 |
76 | Combivent Respimat | $768,925,543 |
77 | Xeloda | $761,832,629 |
78 | Afinitor | $761,796,538 |
79 | Ventolin HFA | $761,324,992 |
80 | Synagis | $755,220,544 |
81 | Zyvox | $732,206,096 |
82 | Bystolic | $719,917,435 |
83 | Sandostatin LAR | $708,264,105 |
84 | Complera | $696,270,123 |
85 | Benicar HCT | $692,128,910 |
86 | Treanda | $691,670,874 |
87 | Gardasil | $683,558,728 |
88 | Zostavax | $679,653,129 |
89 | Pristiq | $660,397,547 |
90 | Erbitux | $660,368,777 |
91 | Focalin XR | $647,720,027 |
92 | Tarceva | $646,108,218 |
93 | Cubicin | $643,649,546 |
94 | Strattera | $640,562,124 |
95 | Latuda | $639,903,393 |
96 | Velcade | $624,619,639 |
97 | Viread | $606,046,798 |
98 | Welchol | $603,644,260 |
99 | Nuvaring | $600,191,343 |
100 | Sprycel | $599,882,414 |
Source: IMS National Prescription Audit, IMS Health. |
Stem Cells therapy
European Clinical Trials Information Network
European Clinical Trials Information Network The European Clinical Trials Information Network revolutionizes how patients across Europe access clinical trial information. By eliminating language barriers, our platform ensures that everyone, regardless of their native language, can Read more…